湖南圣湘生物科技有限公司

About 湖南圣湘生物科技有限公司

Hunan Sun-shine Biotechnology Co., Ltd. was founded by Dr. Li-zhong Dai, a national "1000 Talents Program" distinguished professor who returned to China. The company focuses on molecular diagnostics and gene detection technology, providing integrated solutions that encompass medical diagnostic reagents, instruments, and third-party medical testing services. It has become one of the leading enterprises in China's domestic molecular diagnostics industry, boasting the most advanced technology, the most comprehensive product lines, and a team of over 600 professionals. The company is among the first national demonstration centers for gene detection technology application, a national intellectual property advantage enterprise, and a key high-tech enterprise under the national "Torch Program". The company has assembled one national "1000 Talents Program" expert and six Hunan provincial "100 Talents Program" experts. It has independently developed the high-precision "magnetic bead method" technology, which received the second prize for National Science and Technology Progress, the internationally pioneering "one-step method" technology, the "universal unified extraction" technology, and the "automation" technology, which leads the world in the number of samples that can be tested per batch. The company has led the establishment of national and provincial technological platforms, including the National Demonstration Center for Gene Detection Technology Application, the Hunan Provincial Engineering Research Center for Nucleic Acid Diagnostic Technology, the Hunan Provincial Engineering Technology Research Center for Nucleic Acid Diagnosis and Treatment, and the Hunan Provincial Postdoctoral Research Station Collaborative R&D Center. It has received over 10 major innovation awards, including the second prize for National Science and Technology Progress, the China Patent Excellence Award, and the China Invention and Entrepreneurship Award. The company is leading the industry's development towards "high precision, simplicity, automation, and systematization". The company has developed over 210 products for infectious disease diagnosis, early cancer screening, and pre-natal and post-natal care, among others, with performance surpassing advanced domestic and international standards. It has also developed the world's first universal fully automatic nucleic acid extraction system, filling numerous gaps in China's molecular diagnostics field. The company is making molecular diagnostics, which were previously high-end and expensive, accessible and beneficial to the public. Currently, its products are widely used in over 1,000 benchmark hospitals nationwide and have been exported to more than 30 countries globally, making it the first domestic company to achieve export of molecular diagnostic products.